drugset / Trial / NCT02919878

Neo-adjuvant Chemoradiotherapy Using Infusional Gemcitabine Followed by Surgery for Locally Advanced Rectal Cancer

NCT02919878 ↗

NaSingle-groupOpen-labelTreatment

Summary

Phase II Study of Neo-adjuvant Chemoradiotherapy using infusional Gemcitabine followed by Surgery for Locally Advanced (T3 and T4 or Node positive) Rectal Adenocarcinoma.

Timeline

Start
2014-12
Primary completion
2019-12
Completion
2019-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Gemcitabine Small molecule 100 mg/m2 Intravenous
Background Capecitabine Small molecule 1250 mg/m2 Oral

Indications